Equity Overview
Price & Market Data
Price: $0.23
Daily Change: -$0.022 / 9.58%
Range: $0.226 - $0.262
Market Cap: $774,826
Volume: 26,263
Performance Metrics
1 Week: -10.71%
1 Month: -30.75%
3 Months: -85.55%
6 Months: -88.32%
1 Year: -99.96%
YTD: -87.50%
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.